Michael Greiner - Mar 14, 2024 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Signature
/s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
Stock symbol
AVNS
Transactions as of
Mar 14, 2024
Transactions value $
-$152,980
Form type
4
Date filed
3/15/2024, 11:40 AM
Previous filing
Mar 7, 2024
Next filing
Mar 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Sale -$72.6K -3.8K -2.38% $19.11 156K Mar 14, 2024 Direct
transaction AVNS Common Stock Sale -$13.7K -714 -0.46% $19.12 155K Mar 14, 2024 Direct
transaction AVNS Common Stock Sale -$42.7K -2.23K -1.44% $19.13 153K Mar 14, 2024 Direct
transaction AVNS Common Stock Sale -$6.45K -337 -0.22% $19.14 152K Mar 14, 2024 Direct
transaction AVNS Common Stock Sale -$15.5K -808 -0.53% $19.15 152K Mar 14, 2024 Direct
transaction AVNS Common Stock Sale -$2.11K -110 -0.07% $19.16 151K Mar 14, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

On January 2, 2023, March 4, 2023 and May 7, 2023, a total of 61,472 time-based restricted share units held by the Reporting Person vested (the Vested TRSUs). On March 14, 2024, the Reporting Person completed the sale of 8,000 shares of the Issuer's common stock. The Reporting Person has advised the Issuer that: (i) he intends to use the proceeds from the sale of such shares to satisfy the tax obligations resulting from the vesting of the Vested TRSUs and (ii) he was not in possession of material non-public information regarding the Issuer at the time of such sale.